Your browser doesn't support javascript.
loading
Ibrutinib therapy for lymphoplasmacytic lymphoma.
Helber, Margaret J; Moore, Jeremiah E; Williams, AnnaLynn M; Meacham, Philip J; Rothberg, Paul G; Zent, Clive S.
Afiliación
  • Helber MJ; Department of Pharmacy, University of Rochester Medical Center, Rochester, New York.
  • Moore JE; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York.
  • Williams AM; Department of Pharmacy, University of Rochester Medical Center, Rochester, New York.
  • Meacham PJ; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York.
  • Rothberg PG; Department of Public Health Sciences, University of Rochester Medical Center, Rochester, New York.
  • Zent CS; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York.
Am J Hematol ; 92(9): E542-E544, 2017 09.
Article en En | MEDLINE | ID: mdl-28543765

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pirazoles / Pirimidinas / Macroglobulinemia de Waldenström / Terapia Molecular Dirigida / Antineoplásicos Tipo de estudio: Etiology_studies / Observational_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Año: 2017 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pirazoles / Pirimidinas / Macroglobulinemia de Waldenström / Terapia Molecular Dirigida / Antineoplásicos Tipo de estudio: Etiology_studies / Observational_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Año: 2017 Tipo del documento: Article Pais de publicación: Estados Unidos